Gracey Craig 4

What Happened
Gracey Craig, Chief Accounting Officer of Omada Health, exercised 1,041 stock options on July 13, 2026 at an exercise price of $6.57 per share (total exercise cost $6,839) and sold the same 1,041 shares in an open-market transaction at $24.00 per share for total gross proceeds of $24,984. The filing also shows the derivative/security underlying the options was cancelled (recorded at $0) as part of the exercise/conversion.

Key Details

• Transaction date: July 13, 2026; Form 4 filed July 15, 2026 (appears timely).
• Exercise: 1,041 shares exercised @ $6.57 = $6,839 (transaction code M).
• Sale: 1,041 shares sold @ $24.00 = $24,984 (transaction code S).
• Derivative/cancellation entry: 1,041 option shares recorded disposed @ $0 (reflects conversion of the option).
• Plan note: Transaction made pursuant to a 10b5-1 trading plan adopted March 13, 2026.
• Vesting note: The option vests 25% after one year from Sept 9, 2024, then 1/48th monthly thereafter; fully vested on the fourth anniversary of Sept 9, 2024.
• Shares owned after the transaction: not specified in the supplied data.

Context
This was an exercise-and-sell (cashless-style) transaction: Craig exercised options and immediately sold the resulting shares, generating net proceeds (sale proceeds minus exercise cost). The trade was conducted under an established 10b5-1 plan, which indicates preplanned execution rather than an ad‑hoc market-timing decision. This type of insider activity is often routine when executives monetize vested option grants; it is factual reporting rather than an explicit signal of company outlook.